Sunday, October 1, 2023
Clinical Advances in
Pertussis, or whooping cough, is a highly contagious lower respiratory tract infection caused by Bordetella pertussis and represents an important cause of infant death worldwide. Despite high vaccination rates in some countries, the incidence of pertussis continues to rise in persons of all ages and presents an important global public health concern. Increased control of pertussis depends, in part, on implementing strategies to maximize the effectiveness of available vaccines to protect those at risk of infection.
This independent educational activity is supported by
See All
See All
Steering Committee Chair
Professor Emeritus, University of Pennsylvania, The Wistar Institute, Philadelphia, Pennsylvania, United States
Former Head, Research Unit, Institut Pasteur; Director, National Reference Centres for Pertussis and Diphtheria, Paris, France
Head, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia
Steering Committee Chair
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: GlaxoSmithKline; Inovio; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Sanofi
Served as a speaker or a member of a speakers bureau for: GlaxoSmithKline; Inovio; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Sanofi
Owns stock, stock options, or bonds from: Dynavax Technologies Corporation; Glycovaxyn AG; Sanofi
Has disclosed the following relevant financial relationships.
Served as an advisor or consultant for: GlaxoSmithKline
Served as a speaker or a member of a speakers bureau for: Sanofi Pasteur
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: Zeria Pharmaceutical Co., Ltd.
Received grants for clinical research from: GlaxoSmithKline; Novartis Pharmaceuticals Corporation
Member of World Health Organization Strategic Advisory Group of Experts.